Browse by author
Lookup NU author(s): Dr Andrew Robertson, Professor Christopher WardORCiD, Professor Jeffrey Pearson, Emeritus Professor Nick Europe-Finner, Professor John Dark, Professor Michael Griffin
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Lung transplantation is an accepted treatment strategy for end-stage lung disease; however, bronchiolitis obliterans syndrome is a major cause of morbidity and mortality. This review explores the role of gastroesophageal reflux disease in bronchiolitis obliterans syndrome and the evidence suggesting the benefits of anti-reflux surgery in improving lung function and survival. There is a high prevalence of gastroesophageal reflux in patients post lung transplantation. This may be due to a high preoperative incidence, vagal damage and immunosuppression. Reflux in these patients is associated with a worse outcome, which may be due to micro-aspiration. Anti-reflux surgery is safe in selected lung transplant recipients; however there has been one report of a postoperative mortality. Evidence is conflicting but may suggest a benefit for patients undergoing anti-reflux surgery in terms of lung function and survival; there are no controlled studies. The precise indications, timing, and choice of fundoplication are yet to be defined, and further studies are required. (Ann Thorac Surg 2010; 89: 653-60) (C) 2010 by The Society of Thoracic Surgeons
Author(s): Robertson AGN, Ward C, Pearson JP, Corris PA, Dark JH, Griffin SM
Publication type: Review
Publication status: Published
Journal: Annals of Thoracic Surgery
Year: 2010
Volume: 89
Issue: 2
Pages: 653-660
Print publication date: 22/01/2010
ISSN (print): 0003-4975
ISSN (electronic): 1552-6259
Publisher: ELSEVIER SCIENCE INC
URL: http://dx.doi.org/10.1016/j.athoracsur.2009.09.001
DOI: 10.1016/j.athoracsur.2009.09.001
